STERIS director plans $953K Rule 144 share sale

STERIS plc (STE) director Richard C. Breeden filed a Rule 144 notice for a proposed sale of up to 4,110 ordinary shares through Charles Schwab on the NYSE, with an indicated aggregate market value of $953,114.00, targeted for 08/18/2026.

Rhea-AI Filing Summary

STERIS plc (STE) director Richard C. Breeden filed a Rule 144 notice for a proposed sale of up to 4,110 ordinary shares through Charles Schwab on the NYSE, with an indicated aggregate market value of $953,114.00, targeted for 08/18/2026. The shares to be sold were acquired from STERIS plc on 08/13/2025 for cash in an “Exercise & Hold” transaction. In the preceding three months, Breeden reported selling 1,481 shares of STERIS plc on 06/02/2026 for $310,285.00.

Key Figures

Shares proposed for sale: 4,110 shares Aggregate market value of proposed sale: $953,114.00 Proposed sale date: 08/18/2026 +3 more

6 metrics

Shares proposed for sale 4,110 shares Ordinary shares of STERIS plc in Rule 144 notice

Aggregate market value of proposed sale $953,114.00 Value for 4,110 STERIS plc ordinary shares in Rule 144 filing

Proposed sale date 08/18/2026 Target date for sale of 4,110 STERIS plc shares

Acquisition date of shares to be sold 08/13/2025 Date shares were acquired via Exercise & Hold for cash

Shares sold in past 3 months 1,481 shares STERIS plc shares sold by Richard C. Breeden on 06/02/2026

Value of shares sold in past 3 months $310,285.00 Total value of 1,481 STERIS plc shares sold on 06/02/2026

Key Terms

Rule 144, Exercise & Hold, Ordinary Shares

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise & Hold financial

"Ordinary | 08/13/2025 | Exercise & Hold | STERIS plc"

Ordinary Shares financial

"Ordinary Shares | Charles Schwab & Co., Inc."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sale is STERIS plc (STE) director Richard C. Breeden planning under Rule 144?

Richard C. Breeden filed to sell up to 4,110 ordinary shares of STERIS plc under Rule 144. The proposed sale, via Charles Schwab on the NYSE, has an indicated aggregate market value of $953,114.00 and is targeted for 08/18/2026.

When were the STERIS plc (STE) shares to be sold by Richard C. Breeden acquired?

The 4,110 STERIS plc shares covered by this notice were acquired on 08/13/2025. They were obtained from STERIS plc for cash in an “Exercise & Hold” transaction before the planned Rule 144 sale.

What is the recent sale history for STERIS plc (STE) shares by Richard C. Breeden?

In the past three months, Richard C. Breeden reported selling 1,481 STERIS plc shares. That sale occurred on 06/02/2026 and had a total value of $310,285.00, as disclosed alongside the new proposed Rule 144 transaction.

Which broker and market are involved in Richard C. Breeden’s planned sale of STERIS plc (STE) shares?

The proposed Rule 144 sale will be executed through Charles Schwab & Co., Inc.. The filing lists trading on the NYSE for the 4,110 ordinary shares of STERIS plc covered by this notice of proposed sale.

What is the aggregate market value of STERIS plc (STE) shares covered by Richard C. Breeden’s Rule 144 filing?

The Rule 144 notice lists an aggregate market value of $953,114.00 for the 4,110 ordinary shares proposed for sale. This figure reflects the value used for the notice and is tied to the planned sale on or about 08/18/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 05:27 PM Accepted by SEC EDGAR 08/18/2026 - 05:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001300622
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	STERIS plc
SEC File Number	001-38848
Address of Issuer	70 SIR JOHN ROGERSON'S QUAY DUBLIN IRELAND 2
Phone	35312322000
Name of Person for Whose Account the Securities are To Be Sold	Breeden Richard C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	4110	953114.00	97500110	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/13/2025	Exercise & Hold	STERIS plc			4110	08/13/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard C Breeden 70 SIR JOHN ROGERSON'S QUAY DUBLIN L2 2	STERIS plc	06/02/2026	1481	310285.00

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Richard C Breeden
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)